Stay updated on Bemcentinib in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page
- Check6 days agoChange DetectedRecruitment status has been updated to indicate the study is no longer looking for participants. The page also adds How to Read a Study Record, Common Questions, and How to Join a Study, and standardizes the Intervention/Treatment heading for consistency.SummaryDifference0.3%

- Check13 days agoChange DetectedThe page revision label was updated to v3.5.5, indicating a newer build of the page. This update is a maintenance detail and does not alter the study details or eligibility criteria on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.5.4', indicating a minor update to the page’s version, while the previous revision label 'v3.5.3' was removed.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page’s release/build revision indicator has been updated from `v3.5.2` to `v3.5.3` at the bottom of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.